Glypican 1 Antibody [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-28590JF549
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
ELISA, Flow Cytometry, Functional
Label
Janelia Fluor 549
Antibody Source
Recombinant Monoclonal Mouse IgG1 expressed in CHO
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
GPC1 / Glypican-1
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Description
The heavy chain type is muIgG1, and the light chain type is mKappa. It has a predicted MW of 145.5 kDa.
Patent #: US20190010247
Patent #: US20190010247
Applications for Glypican 1 Antibody [Janelia Fluor® 549]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Functional
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Glypican 1
Alternate Names
GPC1
Gene Symbol
GPC1
Additional Glypican 1 Products
Product Documents for Glypican 1 Antibody [Janelia Fluor® 549]
Product Specific Notices for Glypican 1 Antibody [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...